Pigment epithelium-derived factor increases in type 2 diabetes after treatment with metformin

Clinical Endocrinology

Volumn 77, Issue 6, 2012, Pages 852-856

  Akin, Şafak ^a   Aksoy, Duygu Yazgan ^b   Çinar, Neşe ^a   Aydin, Kadriye ^a   Karaaǧaoǧlu, Ergun ^a   Ariyürek, MacIt ^a   Gülçelik, Neşe Ersöz ^a   Usman, Aydan ^a   Gürlek, Alper ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; PIGMENT EPITHELIUM DERIVED FACTOR;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; BODY FAT DISTRIBUTION; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EYE PROTEINS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; METFORMIN; MIDDLE AGED; NERVE GROWTH FACTORS; PROSPECTIVE STUDIES; SERPINS; WAIST CIRCUMFERENCE;

EID: 84869074311     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04341.x     Document Type: Article

References (27)

1. Filleur, S., Nelius, T., de Riese, W., et al,. (2009) Characterization of PEDF: a multi-functional serpin family protein. Journal of Cellular Biochemistry, 106, 769-775.
2. Yamagishi, S., Matsui, T., Nakamura, K., et al,. (2008) Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications. Current Drug Targets, 9, 1025-1029.
3. Manalo, K.B., Choong, P.F., Becerra, S.P., et al,. (2011) Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective. Expert Opinion on Therapeutic Patents, 21, 121-130.
4. Manalo, K.B., Choong, P.F., &, Dass, C.R., (2011) Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis. Molecular Carcinogenesis, 50, 67-72.
5. Wang, M., Wang, J.J., Li, J., et al,. (2009) Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes. American Journal of Physiology-Endocrinology and Metabolism, 297, E1378-E1387.
6. Crowe, S., Wu, L.E., Economou, C., et al,. (2009) Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metabolism, 10, 40-47.
7. Kratchmarova, I., Kalume, D.E., Blagoev, B., et al,. (2002) A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Molecular and Cellular Proteomics, 1, 213-222.
8. Sabater, M., Moreno-Navarrete, J.M., Ortega, F.J., et al,. (2010) Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. The Journal of Clinical Endocrinology and Metabolism, 95, 4720-4728.
9. Jenkins, A., Zhang, S.X., Gosmanova, A., et al,. (2008) Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Research and Clinical Practice, 82, e5-e7.
10. Maeda, S., Matsui, T., Takeuchi, M., et al,. (2011) Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis. Pharmacological Research, 63, 241-248.
11. Yang, S.L., Chen, S.L., Wu, J.Y., et al,. (2010) Pigment epithelium-derived factor induces interleukin-10 expression in human macrophages by induction of PPAR gamma. Life Sciences, 87, 26-35.
12. Xu, Z., Fang, S., Zuo, Y., et al,. (2011) Combination of PEDF with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by down-regulating VEGF expression and angiogenesis. Cancer Science, 102, 1789-1798.
13. Zolochevska, O., Yu, G., Gimble, J.M., et al,. (2011) PEDF and MDA-7 cytokine gene therapies delivered by adipose-derived mesenchymal stem cells are effective in reducing prostate cancer cell growth. Stem Cells and Development, doi: 10.1089/scd.2011.0247.
14. Feng, C.C., Wang, P.H., Ding, Q., et al,. (2011) Expression of pigment epithelium-derived factor and tumor necrosis factor-alpha is correlated in bladder tumor and is related to tumor angiogenesis. Urologic Oncology, doi: 10.1016/j.urolonc.2010.12.001.
15. Yang, S., Li, Q., Zhong, L., et al,. (2011) Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 96, 831-836.
16. Chen, C., Tso, A.W., Law, L.S., et al,. (2010) Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study. The Journal of Clinical Endocrinology and Metabolism, 95, 5074-5081.
17. Nathan, D.M., Buse, J.B., Davidson, M.B., et al,. (2006) Professional Practice Committee, American Diabetes Association; European Association for the Study of Diabetes. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia, 49, 1711-1721. (Pubitemid 44025023)
18. Diaz, R., (2011) Reproductive endocrinology: diabetes, puberty and pcos risk. Nature Reviews Endocrinology, 7, 3.
19. Aguilar, R.B., (2011) Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment success. Clinical Therapeutics, 33, 408-424.
20. Souto, S.B., Souto, E.B., Braga, D.C., et al,. (2011) Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM). European Journal of Clinical Pharmacology, 6, 653-661.
21. Yanovski, J.A., Krakoff, J., Salaita, C.G., et al,. (2011) Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes, 60, 477-485.
22. Famulla, S., Lamers, D., Hartwig, S., et al,. (2011) Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. International Journal of Obesity, 35, 762-772.
23. Borg, M.L., Andrews, Z.B., Duh, E.J., et al,. (2011) Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes, 60, 1458-1466.
24. Sabater, M., Moreno-Navarrete, J.M., Ortega, F.J., et al,. (2010) Circulating pigment-epithelium growth factor levels are associated with insulin resistance and decrease after weight loss. The Journal of Clinical Endocrinology and Metabolism, 95, 4720-4728.
25. Tschoner, A., Sturm, W., Ress, C., et al,. (2011) Effect of weight loss on serum pigment epithelium-derived factor levels. European Journal of Clinical Investigation, 41, 937-942.
26. Li, D., (2011) Metformin as an Antitumor Agent in Cancer Prevention and Treatment. Journal of Diabetes, 3, 320-327.
27. Hosono, K., Endo, H., Takahashi, H., et al,. (2010) Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prevention Research, 3, 1077-1083.